GRAL - NASDAQ

GRAIL, Inc.

GRAIL, Inc.

GRAL·NASDAQ

$61.13

-5.1%
HealthcareMedical - Diagnostics & Research

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$2.62B
EPS-11.1100
P/E Ratio-5.50
Earnings Date08/11/2026
GRAIL, Inc.

GRAIL, Inc. Fair Value Envelope

GRAL · NASDAQ

Our analysis suggests that GRAL has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $61.13, this represents a potential HIDDEN relative to our calculated worth for GRAIL, Inc..

HIDDEN
Intrinsic Value
Current Price: $61.13

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value-$25.6B
+ Cash & Equivalents$249.7M
Firm Value-$25.4B
- Debt$98.0M
Equity Value-$25.5B
/ Shares Outstanding34,967,211B
DCF Value-$728
OVERVALUED BY 1291%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
-$444.5M
-$660.8M
-$982.3M
-$1.5B
-$2.2B
-$3.2B
-$4.8B
-$7.1B
-$10.6B
-$15.8B
Maintenance CapEx
-$270.3K
-$401.8K
-$597.2K
-$887.8K
-$1.3M
-$2.0M
-$2.9M
-$4.3M
-$6.4M
-$9.6M
Owner Earnings
-$444.8M
-$661.2M
-$982.9M
-$1.5B
-$2.2B
-$3.2B
-$4.8B
-$7.1B
-$10.6B
-$15.8B
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
-$411.8M
-$566.8M
-$780.2M
-$1.1B
-$1.5B
-$2.0B
-$2.8B
-$3.9B
-$5.3B
-$7.3B
Terminal Value represents 0.0% of Enterprise Value
Negative Owner Earnings
This company generates negative free cash flow. Consider adjusting maintenance CapEx percentage or check the financial data.

Related Guides

Blog Categories

Continue your GRAL research with focused valuation guides.

DCF Modeling

Improve assumptions for intrinsic value accuracy.

Forecasting

Calibrate growth paths and terminal value behavior.

WACC

Refine discount-rate logic for valuation quality.

Cost of Capital

Match risk profile to expected return assumptions.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.